Cellosaurus logo
expasy logo

Cellosaurus HAK-3 (CVCL_E419)

[Text version]
Cell line name HAK-3
Accession CVCL_E419
Resource Identification Initiative To cite this cell line use: HAK-3 (RRID:CVCL_E419)
Comments Population: Japanese.
Doubling time: ~26 hours (Note=At 52th passage) (PubMed=10493947).
Derived from site: In situ; Liver; UBERON=UBERON_0002107.
Disease Hepatitis C infection (NCIt: C3098)
Adult hepatocellular carcinoma (NCIt: C7956)
Adult hepatocellular carcinoma (ORDO: Orphanet_210159)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Age at sampling 63Y
Category Cancer cell line
Publications

PubMed=10347112; DOI=10.1002/hep.510290624
Yano H., Iemura A., Haramaki M., Ogasawara S., Takayama A., Akiba J., Kojiro M.
Interferon alfa receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines.
Hepatology 29:1708-1717(1999)

PubMed=10493947; DOI=10.3892/ijo.15.4.669
Utsunomiya I., Iemura A., Yano H., Akiba J., Kojiro M.
Establishment and characterization of a new human hepatocellular carcinoma cell line, HAK-3, and its response to growth factors.
Int. J. Oncol. 15:669-675(1999)

Cross-references
Encyclopedic resources Wikidata; Q54872382
Entry history
Entry creation22-Oct-2012
Last entry update29-Jun-2023
Version number10